Reveleer Unveils Global Capability Center in India to Accelerate AI-Powered Value-Based Care Solutions

Delivering around the clock innovation to its customers, Reveleer enhances its scalability, operational efficiency, and service delivery

GLENDALE, Calif., March 11, 2025 /PRNewswire/ — Reveleer, the industry’s pioneering value-based care platform, today announced the opening of a global capability center (GCC) in the IT corridor OMR in Chennai, India. This expansion marks a key milestone in the company’s ongoing efforts to scale operations and meet the growing demand for its innovative AI-powered, intelligent automation solutions.

The expansion comes as Reveleer continues to experience significant growth. The team in India will enhance scalability, operational efficiency, and service delivery, while partnering with U.S.-based team members and customers. By opening the GCC in India, Reveleer strengthens its global workforce, supporting product, engineering, operations, medical coding, and quality assurance.

“This expansion is a direct response to increasing demand for our value-based care solutions and to provide the best possible outcomes to our customers,” said Jay Ackerman, CEO of Reveleer. “We’ve been fortunate to work alongside exceptional partners in India since 2016, and our expansion will allow us to engage a deep pool of talent, accelerate innovation, and expand our ability to help payers and providers improve efficiency, enhance patient care, and strengthen their financial performance.”

Reveleer has appointed industry veteran Shanmugam Nagappan as Managing Director for India, tasked with setting up and growing the GCC in Chennai. Before joining Reveleer, Shanmugam was COO at Replicon India, and Managing Director (India) at IMMO, where he established and expanded the technology and global operations hubs across multiple cities in India.

“I am thrilled to be joining Reveleer at such an exciting time for the company. Our India team will play a strategic role in advancing Reveleer’s business initiatives and innovation, operating as a seamless extension of our U.S. counterparts,” said Shanmugam Nagappan, Managing Director, GCC. “We are committed to supporting our customers and colleagues, while providing local teams with the resources needed to further our mission.”

Reveleer is committed to delivering cutting-edge value-based care solutions and improving healthcare. This expansion underscores the company’s continued leadership and growth within value-based care and the broader healthcare industry.

To learn more about Reveleer, visit reveleer.com.

About Reveleer
As the industry’s pioneering value-based care (VBC) enablement platform, Reveleer is purpose-built to solve the most pressing real-world challenges faced by provider and health-plan organizations today. By unifying retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into one intelligent, AI powered system, Reveleer streamlines fragmented workflows to supercharge productivity, enhance care quality, and optimize performance on high-priority value-based initiatives. To learn more about Reveleer’s value-based care platform, visit us at Reveleer.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/reveleer-unveils-global-capability-center-in-india-to-accelerate-ai-powered-value-based-care-solutions-302397773.html

SOURCE Reveleer

Staff

Recent Posts

Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein

Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapiesNew York, New…

3 hours ago

Celebrating a Decade of Care: Aeroflow Urology Marks 10 Years of Supporting Those Afflicted by Incontinence Across the U.S.A.

Aeroflow Urology's 97% customer satisfaction rating is a testament to the company’s commitment to personalized…

3 hours ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace

EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)…

3 hours ago

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

-- Company taps first EU distributors, Comercial Medico Quirurigca, SA and Durgalab, as the first…

3 hours ago

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI

SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today…

3 hours ago